Humacyte, Inc.
HUMA
$0.57
-$0.01-1.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.27% | -145.02% | -18.45% | 55.33% | 33.54% |
| Total Depreciation and Amortization | -3.98% | -2.29% | -1.11% | 2.92% | 4.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.49% | 86.25% | 205.26% | -137.38% | -63.49% |
| Change in Net Operating Assets | 191.70% | 86.36% | -232.35% | -220.71% | -134.45% |
| Cash from Operations | 16.48% | 12.23% | 1.70% | -4.35% | -24.06% |
| Capital Expenditure | 81.69% | 23.25% | 38.10% | 94.75% | -208.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 81.69% | 23.25% | 38.10% | 94.75% | -208.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 76.07% | -- | 4.61% | -12.75% | -12.89% |
| Issuance of Common Stock | 1,561.09% | -50.83% | 7.39% | 1,151.92% | 310.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -3,705.92% | -5,040.28% | 44.26% |
| Cash from Financing | 2,371.33% | -50.10% | 12.09% | -5,352.18% | 563.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 226.39% | -110.93% | 27.26% | -198.12% | -13.09% |